One Step to a Cure Outcomes of Experimental Treatments for Non-Hodgkins Lymphomas, A Systematic Review
Keywords:
non-hodgkins lymphoma, treatment, CAR-T
Abstract
Non-Hodgkins lymphomas are malignant lymphatic tumors, mainly affecting B cells. Generally occur in children and young adults with different forms of treatment, however most treatments are accompanied by tumoral relapse. Recently, many researches have been made to identify the best treatment with positive long-term outcomes. In that regard, CAR-T cell treatment has been recognized for its accessibility and effect, it utilizes T cells with chimeric antigen receptors, facilitating cancerous cells detection after non-response to the regular R-CHOP treatment. As data-base 26 research papers were found, with 23 of them being utilized.
Downloads
How to Cite
References
Nathan Denlinger, David Bond, Samantha Jaglowski (2021) CAR T-cell therapy for B-cell lymphoma. 46(1), 100826.
Faroogh Marofi, Heshu Rahman, Muhammad Achmad, Klunko Sergeevna, Wanich Suksatan, Walid Abdelbasset, Maria Mikhailova, Navid Shomali, Mahboubeh Yazdanifar, Ali Hassanzadeh, Majid Ahmadi, Roza Motavalli, Yashwant Pathak, Sepideh Izadi, Mostafa Jarahian (2021) RETRACTED: A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions. 12, 681984.
Tanya Siddiqi, Xiuli Wang, M Blanchard, Jamie Wagner, Leslie Popplewell, L Budde, Tracey Stiller, Mary Clark, Laura Lim, Vibhuti Vyas, Christine Brown, Stephen Forman (2021) CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma. 5(20), 4059-4063.
Alexandre Hirayama, Jordan Gauthier, Kevin Hay, Jenna Voutsinas, Qian Wu, Ted Gooley, Daniel Li, Sindhu Cherian, Xueyan Chen, Barbara Pender, Reed Hawkins, Aesha Vakil, Rachel Steinmetz, Utkarsh Acharya, Ryan Cassaday, Aude Chapuis, Tejaswini Dhawale, Paul Hendrie, Hans-Peter Kiem, Ryan Lynch, Jorge Ramos, Mazyar Shadman, Brian Till, Stanley Riddell, David Maloney, Cameron Turtle (2019) The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. 133(17), 1876-1887.
Mitchell Cairo, Auke Beishuizen (2019) Childhood, adolescent and young adult non‐Hodgkin lymphoma: current perspectives. 185(6), 1021-1042.
D Pereg, G Koren, M Lishner (2007) The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. 92(9), 1230-1237.
Stephen Ansell, James Armitage (2005) Non-Hodgkin Lymphoma: Diagnosis and Treatment. 80(8), 1087-1097.
Patrick Reagan, Jonathan Friedberg (2015) Advancing Radioimmunotherapy and Its Future Role in Non-Hodgkin Lymphoma. 11(10), 1543-1553.
Bradley Hunter, Yi-Bin Chen, Caron Jacobson (2019) Allogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin Lymphoma. 33(4), 687-705.
Daniel Silverman, Ebrahim Delpassand, Farzad Torabi, Andre Goy, Peter Mclaughlin, James Murray (2004) Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues. 30(2), 165-172.
Pieternella Lugtenburg, Alexander Lyon, Reinhard Marks, Stefano Luminari (2019) Treatment of Aggressive Non-Hodgkin'S Lymphoma In Frail Patients: Cardiac Comorbidities and Advanced Age. 15(11), 1197-1205.
Taha Al-Juhaishi, Sairah Ahmed (2021) CAR-T in B-Cell Lymphomas: The Past, Present, and Future. 22(4), e261-e268.
Bradley Hunter, Michael Rogalski, Caron Jacobson (2019) Chimeric antigen receptor T-cell therapy for the treatment of aggressive B-cell non-Hodgkin lymphomas: efficacy, toxicity, and comparative chimeric antigen receptor products. 19(11), 1157-1164.
E Copelan (2019) CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients. 33(2), 77.
Yaya Chu, Aliza Gardenswartz, Amanda Termuhlen, Mitchell Cairo (2019) Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma. 185(6), 1055-1070.
Brandon Imber, Joachim Yahalom (2020) Radiotherapy for Non-Hodgkin Lymphomas. 26(3), 217-230.
Paolo Strati, Shabnum Patel, Loretta Nastoupil, Michelle Fanale, Catherine Bollard, Adam Lin, Leo Gordon (2018) Beyond Chemotherapy: Checkpoint Inhibition and Cell-Based Therapy in Non-Hodgkin Lymphoma. 38(38), 592-603.
Ondine Messéant, Roch Houot (2021) CAR-T cells dans les lymphomes : actualités récentes. 108(10), S28-S39.
Pavel Klener, Magdalena Klanova (2020) Drug Resistance in Non-Hodgkin Lymphomas. 21(6), 2081.
Ralph Hauke, James Armitage (2000) Treatment of non-Hodgkin lymphoma. 12(5), 412-418.
Kathleen Mcdaniel, Sophia Chakrabarty, Laycee Parsons, William Maccuaig, Lacey Mcnally (2022) Multimodal Tracking of Theranostic Nanoparticles with CAR T Immunotherapy for Non-Hodgkin Lymphoma. 4(4), 229015.
Auayporn Nademanee (2009) Transplantation for non-Hodgkin lymphoma. 2(4), 425-442.
Zoufang Huang, Vivek Chavda, Rajashri Bezbaruah, Hemant Dhamne, Dong-Hua Yang, Hong-Bing Zhao (2023) CAR T-Cell therapy for the management of mantle cell lymphoma. 22(1), 67.
Published
2023-07-03
Issue
Section
License
Copyright (c) 2023 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.